|
[1] FAN CQ,CRAWFORD JM. Sinusoidal obstruction syndrome(hepatic veno-occlusive disease)[J]. J Clin Exp Hepatol,2014,4(4):332-346.
|
|
[2] DIGNAN FL,WYNN RF,HADZIC N,et al. BCSH/BSBMT guideline:diagnosis and management of veno-occlusive disease(sinusoidal obstruction syndrome)fol owing haematopoietic stem cell transplantation[J]. Br J Haematol,2013,163(4):444-457.
|
|
[3] Chinese Consensus Expert Group on Pathological Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Tumors. Chinese consensus on pathological diagnosis of gastroenteropancreatic neuroendocrine tumors(2013 Edition)[J]. Chin J Pathol,2013,42(10):691-694.(in Chinese)中国胃肠胰神经内分泌肿瘤病理诊断共识专家组．中国胃肠胰神经内分泌肿瘤病理诊断共识(2013版)[J]．中华病理学杂志，2013,42(10):691-694.
|
|
[4] DASARI A,SHEN C,HALPERIN D,et al. Trends in the incidence,prevalence,and survival outcomes in patients with neuroendocrine tumors in the United States[J]. JAMA Oncol,2017,3(10):1335-1342.
|
|
[5] PIAO YN,WANG HY,MA L,et al. MRI features of primary hepatic neuroendocrine tumor[J]. Chin J Radiol,2018,52(2):125-130.(in Chinese)朴勇男，王海屹，马露，等．肝脏原发性神经内分泌肿瘤的MRI特征[J]．中华放射学杂志，2018,52(2):125-130.
|
|
[6] HIJIOKA M,ITO T,IGARASHI H,et al. Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors.[J]. Cancer Sci,2014,105(11):1464-1471.
|
|
[7] FRITZ A,PECRY C,JACK A,et al. International classification of disease for oncology[M]. 3rd Edition. Tr J Ecopathol,2002,8(3-4):121-122.
|
|
[8] GAO WH,XIANG XX. Primary hepatic neuroendocrine neoplasm:A report of 2 cases and literature review[J]. J Clin Hepatol,2017,33(6):1149-1151.(in Chinese)高伟华，向晓星．原发性肝脏神经内分泌肿瘤2例报告并文献复习[J]．临床肝胆病杂志，2017,33(6):1149-1151.
|
|
[9] REILLY FD,DIMLICH RV,CILENTO EV,et al. Hepatic microvascular regulatory mechanisms. II. Cholinergic mechanisms[J]. Hepatology,1982,2(2):230-235.
|
DownLoad: